Cardiometabolic Health Congress

JULY 12, 2023

“In addition to our new online hubs, we are continually designing live education for delivery as satellite symposia at other large conferences such as the American Heart Association or American Diabetes Association Scientific Sessions. ” Learners can see some of the CMHC experts in person on Aug.

Education 40

Education Webinar CME Pediatrics 40

Circulation

NOVEMBER 11, 2024

Evaluate the benefit in important cardiovascular outcomes and safety in elderly patients of a blood pressure control ≤ 130mmHg compared to standard of care.Methods:The research was performed in PubMed, EMBASE, Scielo, LILACS, and Cochrane Central Register of Controlled Trials (CENTRAL) from January 1st, 2013 to May 1st, 2023.

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Dr. Malcolm Kendrick

DECEMBER 8, 2023

8th December 2023 Nothing can simply be ‘good enough’. In addition, there are links to formal risk assessment in cardiovascular disease. With bonus hyperlinks to NICE’s guidelines on hypertension in chronic kidney disease and type I diabetes and type II diabetes and on and on.

Blood Pressure 88

Blood Pressure Blog Document Hypertension 88

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed on age, gender, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, LDL level, left ventricular ejection fraction and various drugs including beta blockers, ACEi and ARBi. Both groups were followed for 12 months.

Cardiogenic Shock 40

Cardiogenic Shock Stroke Strokes Outcomes 40

Circulation

NOVEMBER 11, 2024

Data was obtained from the Hospital Corporation of America (HCA) enterprise-wide database from January 2020 to September 2023 using the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM).

Heart Failure 40

Heart Failure Cardiac Arrest Kidney Disease Atrial Fibrillation 40

Dr. Smith's ECG Blog

SEPTEMBER 5, 2024

A VSR is more likely to occur in patients who are older, female, hypertensive, have chronic kidney disease, and have no prior history of smoking. It commonly occurs in the setting of a first myocardial infarction (MI) in the background of delayed or absent reperfusion therapy.

Cardiogenic Shock 109

Cardiogenic Shock Chest Pain Pericarditis Myocardial Infarction 109

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Risk factors such as smoking, chronic kidney disease, and aging can contribute to plaque formation. Risk factors such as smoking, chronic kidney disease, and aging can contribute to plaque formation.

Risk Factors 40

Risk Factors Blood Pressure Chest Pain Plaque 40

DAIC

DECEMBER 8, 2023

Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

DAIC

MARCH 26, 2025

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). 2023; Oct;29(10):1412-1451. Epub 2023 Sep 26. A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD).

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. billion adults worldwide.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

CardiacWire

OCTOBER 6, 2024

Finerenone is already approved to reduce cardiovascular and kidney disease risks in patients with type 2 diabetes-associated CKD, but not for HF. Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), blocking the mineralocorticoid receptor and its blood pressure effects. in the future.

Heart Failure 59

Heart Failure Blood Pressure Kidney Disease Diabetes 59

Hypertension Journal

OCTOBER 11, 2023

Hypertension, Volume 80, Issue 12 , Page 2591-2600, December 1, 2023. Urgent dialysis rates increased from 1.52% (95% CI, 1.12–2.06) 2.06) to 2.60% (2.17–3.1; Cochran-Armitage trend test;P=0.0071) in 48 235 patients, excluding maintenance dialysis patients.

Hypertension 40

Hypertension Kidney Disease Heart Failure Risk Factors 40

Cardiometabolic Health Congress

JULY 25, 2023

Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1]

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Journal of Cardiovascular Pharmacology

DECEMBER 11, 2024

To compare the efficacy of SGLT2 inhibitors among non-older and older patients we have searched PubMed, Cochrane Central, and Embase until February 2023 for randomized controlled trials (RCTs) investigating SGLT2 inhibitors in older (age 65 years) patients with diabetes mellitus, chronic kidney disease, and chronic heart failure.

Kidney Disease 40

Kidney Disease Heart Failure Myocardial Infarction Cardiovascular Disease 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient ConclusionPatient discharge disposition and comorbidities are driving factors in 90‐day readmissions following an ischemic stroke and differ from 30‐day readmissions.

Risk Factors 40

Risk Factors Stroke Strokes Medicare 40

Stroke Journal

JANUARY 30, 2025

We aimed to examine the prevalence of VRFs among young patients with ICH and evaluate for racial and sex disparities in VRF burden.Methods:Data of patients hospitalized with stroke between January 2014 and December 2023 were collected by Get With the Guidelines-Stroke hospitals participating in the Florida Stroke Registry.

Risk Factors 40

Risk Factors Hemorrhage Stroke Strokes 40

DAIC

JANUARY 23, 2024

11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 As of June 2023, the U.S. Accessed November 8, 2023. Accessed January 18, 2023. μ/L on 0.6

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

Frontiers in Cardiovascular Medicine

JANUARY 5, 2025

This study assessed the real-world use of vericiguat.Material and methodsThis cross-sectional, prospective and multicenter registry (VERISEC) included 776 patients from 43 centres in Spain between December 2022 and October 2023. Of these patients, 79.6% were male, with a mean age of 72.4 (SD:8.7)

Heart Failure 52

Heart Failure Kidney Disease Blood Pressure Diabetes 52

Dr. Smith's ECG Blog

FEBRUARY 10, 2025

Written by Jesse McLaren An 80 year old patient with diabetes/hypertension/ cirrhosis had a recent increase in candesartan for their hypertension, and was also on spirolactone and nadolol. Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference. References 1.

Bradycardia 118

Bradycardia Cardiac Arrest Hypertension ICU 118